Creation of a Biospecimen Repository From Patients With Interstitial Lung Diseases (ILD)

RecruitingOBSERVATIONAL
Enrollment

635

Participants

Timeline

Start Date

August 1, 2018

Primary Completion Date

January 31, 2028

Study Completion Date

January 31, 2028

Conditions
Interstitial Lung Disease
Interventions
OTHER

ILD

100 cc of blood collected from a total of 250 ILD patients. This includes IPF (n=100), fibrotic NSIP (n=50), chronic hypersensitivity pneumonia (n=20), sarcoidosis(n=50), progressive rheumatoid lung disease (n=10) and scleroderma lung disease (n=20)), 10 patients with other fibrosing disease (fibrosing mediastinitis), and 50 patients with lymphangioleiomyomatosis

OTHER

Healthy

100 cc of blood collected from a total of 25 healthy volunteers in order to compare with the ILD participants.

OTHER

Pneumonia

100 cc of blood collected from a total of 100 participants with a diagnosis of pneumonia in order to compare with the ILD participants.

Trial Locations (1)

55905

RECRUITING

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mayo Clinic

OTHER